by mariel | Feb 4, 2026 | Portfolio News
Veradermics closed an oversubscribed Series C in 4Q25 and subsequently completed its IPO, with shares beginning to trade under ticker MANE. by mariel | Jan 27, 2026 | Portfolio News
Nalu’s acquisition by Boston Scientific was completed after quarter-end; LVP2 reported receiving $26.4mm in proceeds. by mariel | Jan 8, 2026 | Portfolio News
IntelyCare completed the acquisition of CareRev, creating a broader workforce platform; the combined business generated >$200M pro forma revenue in CY2025. by mariel | Jan 5, 2026 | Portfolio News
Zenas reported positive Phase 3 INDIGO results and indicated plans to submit a BLA in 2Q26 and MAA in 2H26. by mariel | Dec 22, 2025 | Portfolio News
Viridian submitted its BLA in TED and subsequently announced the BLA received Priority Review with a PDUFA target action date of June 30, 2026. by mariel | Dec 22, 2025 | Portfolio News
Assembly reported positive interim Phase 1b HSV data and announced Gilead exercised its option to license both HSV programs, including a $35M payment and eligibility for milestones/royalties.